GB2188728A - Specific binding assays - Google Patents
Specific binding assays Download PDFInfo
- Publication number
- GB2188728A GB2188728A GB08708200A GB8708200A GB2188728A GB 2188728 A GB2188728 A GB 2188728A GB 08708200 A GB08708200 A GB 08708200A GB 8708200 A GB8708200 A GB 8708200A GB 2188728 A GB2188728 A GB 2188728A
- Authority
- GB
- United Kingdom
- Prior art keywords
- enzyme
- pqq
- analyte
- binding member
- gdh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000009870 specific binding Effects 0.000 title claims description 13
- 238000000159 protein binding assay Methods 0.000 title claims description 7
- 108090000790 Enzymes Proteins 0.000 claims abstract description 26
- 102000004190 Enzymes Human genes 0.000 claims abstract description 26
- 239000012491 analyte Substances 0.000 claims abstract description 17
- 238000003556 assay Methods 0.000 claims abstract description 11
- 108010006591 Apoenzymes Proteins 0.000 claims abstract description 9
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 claims description 86
- 230000027455 binding Effects 0.000 claims description 28
- 230000000694 effects Effects 0.000 claims description 15
- 108010025076 Holoenzymes Proteins 0.000 claims description 14
- 239000000758 substrate Substances 0.000 claims description 9
- 230000021615 conjugation Effects 0.000 claims description 4
- 230000009471 action Effects 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims description 2
- 239000005515 coenzyme Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 4
- 239000002243 precursor Substances 0.000 abstract description 2
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 25
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 10
- 239000010439 graphite Substances 0.000 description 9
- 229910002804 graphite Inorganic materials 0.000 description 9
- 238000007792 addition Methods 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 150000001718 carbodiimides Chemical class 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 229960004452 methionine Drugs 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 2
- 229930195722 L-methionine Natural products 0.000 description 2
- 108090001090 Lectins Proteins 0.000 description 2
- 102000004856 Lectins Human genes 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 125000002843 carboxylic acid group Chemical group 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- 239000003822 epoxy resin Substances 0.000 description 2
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical class [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- YTOVAWUSMUMHIM-UHFFFAOYSA-N iron(2+);5-methylcyclopenta-1,3-diene Chemical compound [Fe+2].C[C-]1C=CC=C1.C[C-]1C=CC=C1 YTOVAWUSMUMHIM-UHFFFAOYSA-N 0.000 description 2
- 239000002523 lectin Substances 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 239000007974 sodium acetate buffer Substances 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- WOAHJDHKFWSLKE-UHFFFAOYSA-N 1,2-benzoquinone Chemical group O=C1C=CC=CC1=O WOAHJDHKFWSLKE-UHFFFAOYSA-N 0.000 description 1
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- ULGJWNIHLSLQPZ-UHFFFAOYSA-N 7-[(6,8-dichloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-n-[2-(1h-indol-3-yl)ethyl]heptanamide Chemical compound C1CCCC2=NC3=CC(Cl)=CC(Cl)=C3C(NCCCCCCC(=O)NCCC=3C4=CC=CC=C4NC=3)=C21 ULGJWNIHLSLQPZ-UHFFFAOYSA-N 0.000 description 1
- 241000588626 Acinetobacter baumannii Species 0.000 description 1
- 241000588624 Acinetobacter calcoaceticus Species 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 229920003319 Araldite® Polymers 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- 108020005199 Dehydrogenases Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 150000008546 L-methionines Chemical class 0.000 description 1
- 108030006769 Methanol dehydrogenases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 108010003977 aminoacylase I Proteins 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229940075397 calomel Drugs 0.000 description 1
- -1 carbohydrate carbohydrate Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000012875 competitive assay Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000002484 cyclic voltammetry Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 108010054770 glucose dehydrogenase (pyrroloquinoline-quinone) Proteins 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 108010036691 methylamine dehydrogenase Proteins 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 125000006203 morpholinoethyl group Chemical group [H]C([H])(*)C([H])([H])N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H] 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- VLPADTBFADIFKG-UHFFFAOYSA-N phanquone Chemical compound C1=CN=C2C(=O)C(=O)C3=NC=CC=C3C2=C1 VLPADTBFADIFKG-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000007420 reactivation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229910001868 water Inorganic materials 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
An analyte is detected in an enzyme-linked assay, wherein the presence of a first enzyme is related to the amount of analyte. The first enzyme converts an inactive precursor of PQQ to PQQ or an active analogue thereof. The PQQ complements an apo-enzyme such as apo-GDH to form an active second enzyme (GDH). The second enzyme catalyses a reaction leading to a detectable signal. This signal is preferably measured bioelectrochemically such as by a GDH electrode as shown in Fig. 1. <IMAGE>
Description
SPECIFICATION
Specific binding assays
The present invention relates to specific binding assays.
The present invention seeks to provide improvements in assays for specific binding wherein the binding is detected by a signal generated by a secondary event dependent on the extent of binding. The signal, of the present invention, is generated by the reconstitution of a holoenzyme, such as the quinoprotein glucose dehydrogenase, from the apo-enzyme and co-enzyme or prosthetic group.
According to the present invention there is provided a specific binding assay for an analyte which comprises:
(a) binding of a specific binding pair (sbp) to an extent related to the presence of the analyte, which sbp comprises an enzyme;
(b) release of a co-enzyme from a derivative thereof by the action of said enzyme, the derivative being a substrate for said enzyme;
(c) re-constitution of a holo-enzyme from the co-enzyme and an apo-enzyme; and
(d) detection of the holo-enzyme;
wherein the co-enzyme derivative does not combine with the apo-enzyme to reconstitute substantial holo-enzyme activity.
In a one form the co-enzyme is 2,7,9-tricarboxy-1H-pyrrolo-(2,3-flquinoline-4,5-dione (POO) or an analogue thereof which reconstitutes holo-enzyme activity, and the apo-enzyme is a quinoprotein.
Suitably, the specific binding pair comprises an immobilised binding member specific for an analyte and a second binding member conjugated to an enzyme. Suitably, the second binding member is either specific for the immobilised binding member or the analyte. For example, the second binding member may compete with the analyte for conjugation with the immobilised binding member, or the immobilised binding member may compete with the analyte for conjugation with the second binding member. Alternatively, the analyte may contain a site which binds specifically to the immobilised binding member and a different site which binds specifically to the second binding member.
Generally, the enzymic release of the co-enzyme provides primary amplification. Suitably, the holo-enzyme generates a signal, which is preferably an electrochemical signal though it also may be a spectrophotometric signal. Generally, the action of the holo-enzyme provides secondary amplification.
In order that the present invention may be more clearly understood, it will be further illustrated by way of example only and with reference to the drawings, wherein:
Figure 1 shows a GDH electrode in cross-section; and
Figure 2 is a graph showing a response of a PQQ depleted GDH electrode.
Applications of modified PQO and apo-GDH in specific binding assays
Bacterial glucose dehydrogenase (GDH) is a member of a new, and increasingly important, quinoprotein class of dehydrogenases (Duine and Frank, 1981). Some alcohol dehydrogenases, some methanol dehydrogenases and some methylamine dehydrogenases are further examples (Duine and Frank, 1981). GDH was originally purified from Bacterium anitratum (Hauge, 1960) and it has now been found in a wide variety of gram-negative organisms (van Schie, et al., 1984).
The GDH prosthetic group, 2,7,9-tricarboxy-1 H-pyrrolo(2,3-l)-quinoline-4,5-dione (pyrroloquinoline quinone) (PQQ), was identified by two independent research groups (Salisbury, et al., 1979;
Duine, et al., 1980), and has been synthesised by a number of routes (Corey and Tramontano, 1981; Gainor and Weinreb, 1981; Hendricksen and de Vries, 1985; MacKenzie, et al., 1983;
Buchi, et al., 1985). Apo-GDH (GDH from which PQQ has been removed) from Acinetobacter calcoaceticus, Pseudomonas aeruginosa and Klebsiella aerogenes strains has been shown to act as a highly specific biological test for PQQ (Duine, et al., 1983). The relationship between GDH activity and PQQ concentration was linear between 2 and 60 nM, and PQQ adducts had negligible activity in this test (Duine, et al., 1983).
PQQ forms addition compounds with quinoprotein substrates, activators and stabilisers e.g.
alcohols, amines and cyanide (Dekker, et al., 1982). The chemical and electrochemical properties of a number of derivatives and analogues of PQQ have been investigated in detail (Sleath, et al., 1985). The close analogue of PQO, 7,9-didecarboxy PQQ, was shown to possess electrochemical and dynamic properties which were virtually indistinguishable from those of PQQ, but it was found to have no discernable activity with apo-GDH. However, 4,7-phenanthroline-5,6-dione, which also had similar electrochemical properties to PQQ (Eckert and Bruice, 1983) was found to produce activity with apo-GDH (Conlin, et al., 1985). However, in the reconstitution assay it was found to produce thirty times less activity than synthetic PQQ.Duine, et al (1980) demonstrated that a range of phenanthroline-diones and PQQ derivatives which were very closely related to
PQQ were unable to restore the activity to apo-GDH on reconstitution. Another derivative of
PQQ, the trimethyl ester (PQQTME), was synthesised (Corey and Tramontano, 1981) and used to catalyse the oxidation of alcohols in a non-enzymic system. However, this compound was not investigated for biological activity with apo-GDH.
Thus, PQQ and a variety of closely related compounds have been synthesised. Most of these have been tested for biological activity with apo-GDH but only one has shown any activity, and this was thirty times lower than that of PQQ.
The homogeneous kinetics and enzymic mechanism of GDH have been described (D'Costa, et al., 1984; D'Costa, 1986). Second order rate constants for the reduction of a number of electrochemical mediators by soluble GDH have also been determined using direct current cyclic voltammetry (D'Costa, et al., 1986). In addition, GDH has been immobilised on a porous graphite electrode in the presence of 1 ,1'-dimethylferrocene to produce a biosensor for glucose (D'Costa, et al., 1986). Furthermore, a GDH-based biosensor which had been made partially deficient in
PQQ produced a six-fold increase in current over a period of two hours following the addition of 500 nM PQQ. In free solution the rate of re-association of PQQ with apo-GDH can be expected to occur more rapidly (Conlin, et al., 1985).
One example of a specific binding assay is the enzyme-linked immunosorbent assay (ELISA).
One form of the ELISA technique, involving a competitive assay using antigen-enzyme conjugate and immobilised antibody, comprises the following steps.
Immobilisation of antibody to solid phase,
(ii) wash,
(iii) incubate with enzyme-labelled antigen in the presence or absence of standard or sample antigen,
(iv) wash,
(v) incubate with enzyme substrate and determine the presence of product of the enzymatic reaction.
In accordance with the present invention, the enzyme substrate in (v) is a modified enzymati caliy inactive precursor of PQQ, which is converted by the label enzyme to PQQ or an enzymatically active analogue thereof, which is the prosthetic group of secondary apo-enzyme, which is thereby converted to the active holo-enzyme to produce the detectable signal.
From this it can be seen that the concentration of enzyme product (PQQ or active analogue) varies inversely with the concentration of the analyte being measured.
Examples of sbp's which may be used are given in Table 1 below.
Tabie 1: Examples of Specific Binding Pairs
Ligand Anti-ligand antigen specific antibody antibody antigen hormone hormone receptor hormone receptor hormone polynucleotide strand complementary strand avidin biotin biotin avidin protein A immunoglobulin immunoglobulin protein A enzyme enzyme cofactor/substrate enzyme cofactor/substrate enzyme lectins carbohydrate carbohydrate lectins affinity dye protein protein affinity dye
In conventional ELISA techniques the enzyme label is usually one that yields a chromogenic product in a signal-producing system, the concentration of which can be determined spectrophotometrically. In the present example, the primary reaction product (PQQ or active analogue) is measured by the extent to which GDH activity is restored by reconstitution of the holoenzyme.
GDH activity is preferably measured electrochemically though it may be measured spectrophotometrically.
An amperometric assay for GDH is shown below.
glucose > GDHox t mediatorred gluconolactone 2 GDHred )C mediat rox electrode
Electrons are passed from glucose to GDH and then to an electrode by way of a mediator.
The enzyme may either be in free solution with a soluble mediator or co-immobilised with a mediator on an electrode surface as shown in Fig. 1. In the example given below, a ferrocene derivative is used as the mediator. However, a variety of other mediators may used, as may conducting organic salts such as tetrathiafulvalene-tetraquinodimethane (TTF-TCNQ), or either of
TTF or TCNO alone.
Construction of graphite electrodes
Referring to Fig. 1, a GDH electrode 10 was constructed in the following manner:
(i) A 2.5 cm length of 6 mm outside diameter glass tubing 12 was heated at one end 14, turned in, and flattened off without closing the tubing.
(ii) A disc 16 (6 mm diameter) was punched out of a 1 mm thick strip of porous graphite (Union Carbide, Ohio, USA) and washed twice in acetone (30 minutes for each wash with gentle agitation), once in boiling distilled water (1 hour), and dried in an air oven at 100"C.
(iii) The graphite disc 16 was glued to the modified end of the glass tubing 12 by the rim using Araldite (Ciba-Geigy Trade Mark) epoxy resin 18.
(iv) Electrical contact to the disc 16 was made by cementing to it a length of 0.2 mm insulated wire 20 using a drop of electrically conducting (silver-loaded) epoxy resin 22 (Johnson
Matthey Chemicals Ltd., Royston, Herts., UK). Insulation of the electrical contact was made by covering it with an insulating resin 24 comprising a mixture of 9 parts epon resin (grade 815) and 1 part triethylenetetramine catalyst 24 (both obtained from Polysciences Inc., Warrington
PA, USA) and allowing it to set at 60"C in an oven overnight.
(v) The electrode 10 was tested before use for electrical conductivity between the graphite surface 16 and the terminal wire 20.
Immobilisation of GDH onto graphite using water-soluble carbodiimide
The graphite electrode 10 was supported in an inverted position while a 5 Xti drop of 1,1'dimethylferrocene/toluene solution (20 mg ml 1) was piaced on the graphite surface 16 and allowed to dry in air. This immobilises ferrocene intermediate 26 on the graphite surface. After 30 minutes at room temperature the electrode 10 was suspended vertically with the grafoil tip 16 pointing downwards. just into the surface of a 20 mg ml 1 solution of 1-cyclohexyl-3-(2 morpholinoethyl)carbodiimide-metho-p-toluenesulphonate (Sigma Chemical Company) in 200 mM sodium acetate buffer, pH 4.5 for 80 minutes at room temperature.The electrode 10 was washed by immersing the tip in 20 mM sodium acetate buffer, pH 5.5 and then suspended in 1.5 ml ice-cold GDH stock solution to immobilise GDH 28 on the electrode 10. The electrode was then immersed in a high concentrate phosphate buffer which caused the PQQ to leak out of the holo-enzyme leaving apo-GDH 28 on the electrode 10. After five hours the electrode 10 was washed as before then stored in 200 ul sodium buffer, pH 7.0 at 4"C for up to five weeks before use.
A GDH electrode made as above was used in a three-electrode system and was set at 160 mV against the standard calomel electrode. The assay was carried out in 10 mM phosphate, pH 7.0 at 28"C and in a final volume 10 ml.
Fig. 2 shows the response obtained from a PQQ depleted GDH electrode. The electrode was allowed to settle down to a low current of about 0.5 to 1 pA. Addition of 10 ,u1 1M glucose produced a minute rise, and addition of 50 z1 lmM glucose a further small rise. Addition of 5 jtl lmM PQQ produced a large response, causing the current to rise from about 1 jiA to about 5 ,xA, and taking about 2 hours to settle down.
This experiment shows the sensitivity of the electrode to very small amounts of PQQ (here 5 jil lmM PQQ diluted into 10 ml).
Further the comparatively slow reassociation kinetics displayed by the immobilised enzyme compared to that occurring in solution means that quantitative rate measurements can be made as opposed to measuring the extent of reactivation.
Additions of PQQ to blank or normal GDH electrodes produced no response, while additions of glucose to normal GDH electrodes produced normal current increases.
Modification of PQQ
The structure of PQQ is shown below.
The C2, C7 and C9 carboxylic acid groups are potential sites for PQQ modification. Whilst not of catalytic importance the addition of bulky groups onto all or any of the carboxyl carbon atoms could prevent prosthetic group binding to apo-GDH due to steric hindrance. Such modification might also remove the negative charge. Therefore, If one or more of these groups is important in the binding of the prosthetic group to the active-site of GDH, the modification might abolish or seriously impair the binding interaction.
Reactive derivatives of carboxylic acid groups can be readily prepared e.g. acid chlorides, anhydrides, etc., which will undergo reaction with nucleophilic compounds such as amines or alcohols to yield amide and ester linkages respectively. An alternative method of modifying the carboxyl groups of PQQ would be the use of compounds such as carbodiimides. These activate carboxyl groups which are then able to undergo condensation reactions with amino and hydroxyl groups, again yielding amide and ester linkages. Enzymes which are capable of cleaving such bonds include the hydrolases (EC 3.1.). General reaction schemes are shown below.
Examples of possible modifications to POO
A. Preparation of POO acid chloride
PQQ PQQ acid chloride
B. Reaction of an acid chloride with:
(i) an amine
(ii) an alcohol
C. Carbodiimide initiated condensation reactions (i) Acylation of amines
(ii) Esterification with hydroxy groups
Since acid chlorides are highly reactive species, it is sometimes necessary to prevent PQQ acid chloride molecules from reacting with each other. This can be achieved by chemically "protecting" any susceptible groups or alternatively by immobilising it on a solid phase prior to the modification reactions to ensure that PQQ interactions cannot occur.
The nature of the R group will depend on the specificity of the enzyme chosen as the primary amplification label. For example, aminoacylase (EC 3.5.1.14) will cleave amide bonds of N-acyl amino acids. Thus POQ which has been modified with, for example, L-methionine (as shown below) might serve as a substrate for this enzyme, the activity of which would yield native PQQ provided that the nature of the R' group (PQQ) is not a critical factor in substrate binding.
0 R'- + H2N-CH-CO [protecting group] OH (CH2)2 S CH3 (PQQ) (L-methionine) + carbodiimide H20 o Ii R C - NH- CiH - CO [protecting group] (CH2)2 S CH3 When preparing the L-methionine derivative of PQQ, the carboxyl group of the methionine is protected, so as to prevent condensation of amino acid molecules with each other.
The above represents only one of the possible routes to achieving a derivative. Alternatives include modifying the orthoquinone moiety of PQQ which has been shown to be essential for activity or the preparation of analogues by, for example, synthetic pathways.
REFERENCES
D'Costa,E.J. Ph.D. Thesis, Cranfield Institute of Technology (1986).
D'Costa,E.J., Higgins,l.J. and Turner,A.P.F.; "Quinoprotein glucose dehydrogenase and its application in an amperometric glucose sensor."; Biosensors (1986) 2, 71-87.
D'Costa,E.J., Turner,A.P.F., Higgins,l.J., Duine,J.A. and Dokter,P.; "Kinetics of a microbial quinoprotein glucose dehydrogenase."; Soc.Gen.Microbiol.Quart. (1984) 11(1).
Conlin,M., Forrest,H.S. and Bruice,T.C.; "Replacement of methoxatin by 4,7-phenanthroline-5,6dione and the inability of other phenanthroline quinones, as well as 7,9-didecarboxy methoxatin, to serve as cofactors for the methoxatin-requiring glucose dehydrogenase of Acinetobactor calcoaceticus."; Biochem.Biophys.Res.Comm. (1985) 131(2), 564-566.
Eckert,T.S. and Bruice,T.C.; "Chemical properties of phenanthroline quinones and the mechanism of amine oxidation by o-quinones of medium redox potentials."; J.Am.Chem.Soc. (1983)
105, 4431-4441.
Sleath,P.R., Noar,J.B., Eberlein,G.A. and Bruice,T.C.;
"Synthesis of 7,9-didecarboxymethoxatin (4, 5-dihydro-4, 5-dioxo- 1 H-pyrrolo[2,3-f]quinoline-2carboxylic acid) and comparison of its chemical properties with those of methoxatin and analogous o-quinones. Model studies directed toward the action of PQQ-requiring bacterial oxidoreductases and mammalian plasma amine oxidases."; J.Am.Chem.Soc. (1985) 107, 3328-3338.
Dekker,R.H., Duine,J.A., Frank,Jzn.J., Verweil,P.E.J. and Westerling,J.; "Covalent addition of H2O, enzyme substrates and activators to pyrrolo-quinoline quinone, the coenzyme of quinopro teins."; Eur.J.Biochem. (1982) 152, 69-73.
Duine,J.A., Frank,Jzn.J. and Jongjan,J.A.; "Detection and determination of pyrrolo-quinoline quinone, the coenzyme of quinoproteins."; Anal.Biochem. (1983) 133, 239-243.
Buchi,G., Botkin,J.H., Lee,G.C.M. and Yakushijin,K.; "A synthesis of methoxatin."; J.Am.
Chem.Soc. (1985) 107, 5555-5556.
MacKenzie,A.R., Moody,C.J. and Rees,C.W.; "Synthesis of the bacterial coenzyme methoxatin."; J.Chem.Soc.; Chem.Comm. (1983), 1372-1373.
Hendrickson,J.B. and De Vries,J.G.; "Total synthesis of the novel coenzyme, methoxatin.";
J.Org.Chem. (1985) 50, 1688-1695.
Gainor,J.A. and Weinreb,S.M.; "Total synthesis of methoxatin, the coenzyme of methanol dehydrogenase and glucose dehydrogenase. ; J.Org.Chem. (1981) 46, 4317-4319.
Corey,E.J. and Tramontano,A.; "Total synthesis of the quinonoid alcohol dehydrogenase coenzyme (1) of methylotropic bacteria."; J.Am.Chem.Soc. (1981) 103, 5599-5600.
Duine,J.A., Frank,Jzn.J. and Verweil,P.E.J.; "Structure and activity of the prosthetic group of methanol dehydrogenase."; Eur.J.Biochem. (1980) 108, 187-192.
Salisbury,S.A., Forrest,H.S., Cruse,W.B.T. and Kennard,O.; "A novel coenzyme from bacterial primary alcohol dehydrogenase."; Nature (1979) 280, 843-844.
van Schie,B.J., van Dijken,J.P. and Kuenen,J.G.; "Non-coordinated synthesis of glucose dehydrogenase and its prosthetic group, PQQ, in Acinetobacter and Pseudomonas species."; FEMS.Microbiol.Letts. (1984) 24, 133-136.
Hauge,J.G.; "Purification and properties of glucose dehydrogenase and cytochrome b from
Bacterium anitratum."; Biochem. Biophys.Acta. (1960) 45, 250-262.
Duine,J.A. and Frank,Jzn.J.; "Quinoproteins: a novel class of dehydrogenases."; Trends in
Biochem. Sci. (1981) 6, 278-280.
Claims (7)
1. A specific binding assay for an analyte which comprises:
(a) binding of a specific binding pair (sbp) to an extent related to the presence of the analyte, which sbp comprises an enzyme;
(b) release of a co-enzyme from a derivative thereof by the action of said enzyme, the derivative being a substrate for said enzyme;
(c) re-constitution of a holo-enzyme from the co-enzyme and an apo-enzyme; and
(d) detection of the holo-enzyme;
wherein the co-enzyme derivative does not combine with the apo-enzyme to reconstitute substantial holo-enzyme activity;
said coenzyme being 2,7,9-tricarboxy-1 H-pyrrolo-(2,3-l)-quinoline-4,5-dione (pyrroloquinoline quinone) (PQQ) or an analogue thereof which reconstitutes holo-enzyme activity, and the apoenzyme is a quinoprotein.
2. An assay according to claim 1 wherein the specific binding pair comprises an immobilised binding member specific for an analyte and a second binding member conjugated to an enzyme.
3. An assay according to claim 2 wherein the second binding member is either specific for the immobilised binding member or the analyte.
4. An assay according to claim 3 wherein the second binding member competes with the analyte for conjugation with the immobilised binding member, or the immobilised binding member competes with the analyte for conjugation with the second binding member.
5. An assay according to claim 3 wherein the analyte contains a site which binds specifically to the immobilised binding member and a different site which binds specifically to the second binding member.
6. An assay according to claim 1 substantially as described herein.
7. A kit for an assay of any one of the preceding claims.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868608435A GB8608435D0 (en) | 1986-04-07 | 1986-04-07 | Specific binding assays |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB8708200D0 GB8708200D0 (en) | 1987-05-13 |
| GB2188728A true GB2188728A (en) | 1987-10-07 |
Family
ID=10595807
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB868608435A Pending GB8608435D0 (en) | 1986-04-07 | 1986-04-07 | Specific binding assays |
| GB08708200A Withdrawn GB2188728A (en) | 1986-04-07 | 1987-04-06 | Specific binding assays |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB868608435A Pending GB8608435D0 (en) | 1986-04-07 | 1986-04-07 | Specific binding assays |
Country Status (1)
| Country | Link |
|---|---|
| GB (2) | GB8608435D0 (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999019507A1 (en) * | 1997-10-16 | 1999-04-22 | Abbott Laboratories | Biosensor electrode mediators for regeneration of cofactors |
| WO2003097863A1 (en) | 2002-05-16 | 2003-11-27 | F. Hoffmann-La Roche Ag | Method and reagent system having an inactivated enzyme |
| US6736957B1 (en) | 1997-10-16 | 2004-05-18 | Abbott Laboratories | Biosensor electrode mediators for regeneration of cofactors and process for using |
| US7166208B2 (en) * | 2004-03-03 | 2007-01-23 | Stephen Eliot Zweig | Apoenzyme reactivation electrochemical detection method and assay |
| US7172890B2 (en) | 2004-10-28 | 2007-02-06 | Roche Diagnostics Gmbh | Inactivated enzyme variants and associated process and reagent system |
| EP1801229A1 (en) * | 1997-10-16 | 2007-06-27 | Abbott Laboratories | Biosensor electrode |
| US7758812B2 (en) | 2001-12-22 | 2010-07-20 | Roche Diagnostics Operations, Inc. | Analysis system for determining an analyte concentration, taking into consideration sample-and analyte-independent light-intensity changes |
| US8118991B2 (en) | 2001-09-04 | 2012-02-21 | Stephen Eliot Zweig | Apoenzyme reactivation electrochemical detection method and assay |
| US12330211B2 (en) | 2018-06-20 | 2025-06-17 | Relativity Space, Inc. | Multi-diameter wire feeder |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2023607A (en) * | 1978-06-22 | 1980-01-03 | Miles Lab | Specific Binding Assay Method With a Prosthetic Group as a Label Component |
| EP0094161A1 (en) * | 1982-05-07 | 1983-11-16 | Imperial Chemical Industries Plc | Method for determining glucose content of fluid |
| EP0125867A2 (en) * | 1983-05-05 | 1984-11-21 | MediSense, Inc. | Assay systems using enzymes requiring NAD(P) as cofactor |
-
1986
- 1986-04-07 GB GB868608435A patent/GB8608435D0/en active Pending
-
1987
- 1987-04-06 GB GB08708200A patent/GB2188728A/en not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2023607A (en) * | 1978-06-22 | 1980-01-03 | Miles Lab | Specific Binding Assay Method With a Prosthetic Group as a Label Component |
| EP0094161A1 (en) * | 1982-05-07 | 1983-11-16 | Imperial Chemical Industries Plc | Method for determining glucose content of fluid |
| EP0125867A2 (en) * | 1983-05-05 | 1984-11-21 | MediSense, Inc. | Assay systems using enzymes requiring NAD(P) as cofactor |
Non-Patent Citations (2)
| Title |
|---|
| ANALYST (LONDON)VOL. 110 (8)P 925-8 * |
| ANALYTICAL BIOCHEMISTRY VOL. 151 (2)P 263-67 * |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7998337B2 (en) | 1997-10-16 | 2011-08-16 | Abbott Laboratories | Biosensor electrode mediators for regeneration of cofactors |
| US8012341B2 (en) | 1997-10-16 | 2011-09-06 | Abbott Laboratories | Biosensor electrode mediators for regeneration of cofactors |
| US6736957B1 (en) | 1997-10-16 | 2004-05-18 | Abbott Laboratories | Biosensor electrode mediators for regeneration of cofactors and process for using |
| US8241485B2 (en) | 1997-10-16 | 2012-08-14 | Abbott Laboratories | Biosensor electrode mediators for regeneration of cofactors |
| US8221612B2 (en) | 1997-10-16 | 2012-07-17 | Abbott Diabetes Care Inc. | Biosensor electrode mediators for regeneration of cofactors |
| US7504019B2 (en) | 1997-10-16 | 2009-03-17 | Abbott Laboratories | Biosensor electrode mediators for regeneration of cofactors |
| WO1999019507A1 (en) * | 1997-10-16 | 1999-04-22 | Abbott Laboratories | Biosensor electrode mediators for regeneration of cofactors |
| EP1801229A1 (en) * | 1997-10-16 | 2007-06-27 | Abbott Laboratories | Biosensor electrode |
| EP2119795A1 (en) * | 1997-10-16 | 2009-11-18 | Abbott Laboratories | Biosensor electrode |
| US8118991B2 (en) | 2001-09-04 | 2012-02-21 | Stephen Eliot Zweig | Apoenzyme reactivation electrochemical detection method and assay |
| US7758812B2 (en) | 2001-12-22 | 2010-07-20 | Roche Diagnostics Operations, Inc. | Analysis system for determining an analyte concentration, taking into consideration sample-and analyte-independent light-intensity changes |
| WO2003097863A1 (en) | 2002-05-16 | 2003-11-27 | F. Hoffmann-La Roche Ag | Method and reagent system having an inactivated enzyme |
| JP2005528897A (en) * | 2002-05-16 | 2005-09-29 | エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト | Method and reagent system using inactivated enzyme |
| WO2005111230A3 (en) * | 2004-03-03 | 2007-02-01 | Stephen Eliot Zweig | Apoenzyme reactivation electrochemical detection method and assay |
| US7166208B2 (en) * | 2004-03-03 | 2007-01-23 | Stephen Eliot Zweig | Apoenzyme reactivation electrochemical detection method and assay |
| US7517664B2 (en) | 2004-10-28 | 2009-04-14 | Roche Diagnostics Operations, Inc. | Inactivated enzyme variants and associated process and reagent system |
| US7172890B2 (en) | 2004-10-28 | 2007-02-06 | Roche Diagnostics Gmbh | Inactivated enzyme variants and associated process and reagent system |
| US12330211B2 (en) | 2018-06-20 | 2025-06-17 | Relativity Space, Inc. | Multi-diameter wire feeder |
Also Published As
| Publication number | Publication date |
|---|---|
| GB8708200D0 (en) | 1987-05-13 |
| GB8608435D0 (en) | 1986-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1218704A (en) | Assay systems using more than one enzyme | |
| McNeil et al. | Thermostable reduced nicotinamide adenine dinucleotide oxidase: application to amperometric enzyme assay | |
| Ianniello et al. | Immobilized enzyme chemically modified electrode as an amperometric sensor | |
| JP3242923B2 (en) | Electrode and method for detecting hydrogen peroxide | |
| US4840893A (en) | Electrochemical assay for nucleic acids and nucleic acid probes | |
| US5387515A (en) | Process for providing a 6-ketone from morphine or an ether derivative thereof using morphine dehydrogenase | |
| US4376689A (en) | Coenzyme immobilized electrode | |
| Charpentier et al. | Amperometric determination of cholesterol in serum with use of a renewable surface peroxidase electrode | |
| Villalonga et al. | Construction of an amperometric biosensor for xanthine via supramolecular associations | |
| JPH05507195A (en) | Substrate regeneration type biosensor | |
| Mizutani et al. | Amperometric glucose-sensing electrode based on carbon paste containing poly (ethylene glycol)-modified glucose oxidase and cobalt octaethoxyphthalocyanine | |
| GB2188728A (en) | Specific binding assays | |
| Arai et al. | Electrochemical characteristics of D-amino acid oxidase immobilized in a conductive redox polymer | |
| Yao et al. | Amperometric enzyme-immunosensor based on ferrocene-mediated amplification | |
| Loughran et al. | Amperometric detection of histamine at a quinoprotein dehydrogenase enzyme electrode | |
| CA1130739A (en) | Lactate oxidase, process for manufacture thereof and analytical method and kit for the use of the same | |
| JPS6279780A (en) | Quantitative determination of 1,5-anhydroglucitol, enzyme used therefor and production thereof | |
| ERDEM et al. | Electrochemical biosensor based on horseradish peroxidase for the determination of oxidizable drugs | |
| Kelly et al. | Amperometric immunosensor for lactate dehydrogenase LD-1 | |
| Chang et al. | Immobilized-enzyme electrode for nicotinamide adenine dinucleotide (reduced form)(NADH) sensing and application to the kinetic studies of NADH dependent dehydrogenases | |
| Stoytcheva | Electrocatalysis with an acetylcholinesterase immobilized graphite electrode | |
| JPS5816693B2 (en) | electrode | |
| Yabuki et al. | Choline-sensing electrode based on polyethylene glycol-modified enzyme and mediator | |
| Compagnone et al. | Amperometric biosensors for the determination of heavy metals | |
| KR100852255B1 (en) | Trimethylamine detection method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |